Details of the Drug Pharmacogenomic Perturbation Atlas
General Information of Drug (ID: DMYSJRN)
| Drug Name | ||||||
|---|---|---|---|---|---|---|
| Synonyms |
Bromopride hydrochloride; UNII-B7C7WX94Z6; B7C7WX94Z6; 52423-56-0; 4-amino-5-bromo-N-(2-diethylaminoethyl)-2-methoxybenzamide hydrochloride; Cascapride; Opridan; Bromopride HCl; Bromoprid hydrochlorid; EINECS 257-906-6; AC1MI3LY; SCHEMBL8385045; CTK8J0119; AKOS027380919; KB-289931; 4-Amino-5-bromo-N-(2-(diethylamino)ethyl)-2-methoxybenzamide monohydrochloride
| |||||
| Cross-matching ID | ||||||
Consensus Signature of Drug Pharmacogenomic Perturbation (DPP)
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Pharmacogenomic Perturbation Across Diseases and Tissues
|
Bone
Osteosarcoma
|
||||||||||||||||||||||||
